MC
SPRY icon

Matisse Capital’s ARS Pharmaceuticals SPRY Stock Holding History

Matisse Capital’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$990K Buy
56,714
+1,000
+2% +$17.5K 0.47% 70
2025
Q1 		$701K Buy
+55,714
New +$701K 0.37% 86